| Literature DB >> 36157844 |
Elias G Joseph1, Aleksandr Krichmar1, Mohammad Nadir Haider1, Thomas R Duquin1.
Abstract
Background: To evaluate the clinical, functional, radiographic, and survival outcomes in patients undergoing reverse total shoulder arthroplasty (RSA) with uncemented stem fixation for proximal humerus fractures. Materials andEntities:
Keywords: cemented stem fixation; humerus; proximal humerus fracture; reverse arthroplasty for fracture; shoulder arthroplasty; uncemented stem fixation
Year: 2022 PMID: 36157844 PMCID: PMC9500255 DOI: 10.1177/24715492221127686
Source DB: PubMed Journal: J Shoulder Elb Arthroplast ISSN: 2471-5492
Figure 1.Tuberosity healing radiographs.
Figure 2.Unsuitable case for uncemented fixation.
Figure 3.Reverse total shoulder arthroplasty with cemented and uncemented stem.
Groupwise demographic and Pre-surgery clinical characteristics.
| Uncemented
rTSA | Cemented
rTSA | ||
|---|---|---|---|
| Age | 73.94 ± 8.5 | 74.92 ± 8.6 | 0.768 |
| Sex | 15 female, 1 male | 10 female, 2 male | 0.560 |
| Dominant Side | 15 right, 1 left | 12 right | >0.999 |
| Height | 1.58 ± 0.070 | 1.63 ± 0.084 | 0.105 |
| Weight | 77.47 ± 11.9 | 76.33 ± 17.7 | 0.840 |
| Tobacco use | 5 current smokers, 5 previous smokers | 0 current smokers, 8 previous smokers | 0.060 |
| CVD | 9/16 | 2/12 | 0.054 |
| PVD | 2/16 | 1/12 | >0.999 |
| Diabetes Mellitus | 2/16 | 2/12 | >0.999 |
| Surgical Side | 7 right, 9 left | 4 right, 8 left | 0.705 |
| Tuberosity Bone Graft | 7/16 yes | 6/12 yes | 0.743 |
| Antibiotic Cement Type | - | 9 Vancomycin, 3 Gentamycin | - |
| ASA Classification | 0.569 | ||
| 2 | 5 | 5 | |
| 3 | 11 | 7 | |
Groupwise fracture classification.
| Uncemented RSA | Cemented RSA | ||
|---|---|---|---|
| Neer Fracture Classification | 12 4-Part, 4 3-Part | 10 4-Part, 2 3-Part | 0.673 |
| OTA Classification | 12 11-C3, 4 11-B1 | 10 11-C3, 2 11-B1 | 0.673 |
| Head-Split Pattern | 12 Yes, 4 No | 2 Yes, 10 No | >0.999 |
| Fracture-Dislocation | 7 Yes, 9 No | 2 Yes, 10 No | 0.233 |
| Tuberosity Comminution | 7 Yes, 9 No | 7 Yes, 5 No |
*Fisher's Exact Test, 2-sided
Groupwise Post-operative outcomes.
| Uncemented RSA | Cemented RSA | ||
|---|---|---|---|
| Maximum length of follow-up, median (IQR), range | 108 weeks (59.75, 184.5) | 223 weeks (103.5, 282) | 0.110 |
| Complications | 1 infection of prosthetic device (Week 180) and 1 Revision of Tuberosity Nonunion (Week 52) | None | 0.492 |
| QuickDASH | 41.24 ± 25 | 30.8 ± 18.6 | 0.259 |
| ASES | 58.44 ± 26.4 | 74.26 ± 20.4 | 0.144 |
| Visual Analog Score (VAS) | 0.5 (0, 3.75) | 0 (0, 4) | 0.525 |
| Tuberosity Comminution | 7/16 yes | 7/12 yes | 0.445 |
| Greater Tuberosity Healing | 0.283 | ||
| Healed Anatomic | 10 | 4 | |
| Nonunion | 2 | 2 | |
| Resorption | 4 | 6 | |
| Forward Elevation (degrees) | 160 (120, 160) | 140 (112.5, 157.5) | 0.507 |
| External Rotation (degrees) | 40 (30, 50) | 37.5 (25, 43.75) | 0.347 |
| Post-op Internal Rotation | 15 between T4-LS junction, 1 below LS junction | 7 between T4-LS junction, 5 below LS junction | 0.057 |
Follow-up (in weeks), VAS and ROM presented as median (inter-quartile range) and compared using non-parametric t-test.
Figure 4.Kaplan Meier survival graph between groups log rank test is not significantly different between groups (χ2 = 2.381, p = 0.123).